CONECTA Trademark

Trademark Overview


On Monday, March 25, 2024, a trademark application was filed for CONECTA with the United States Patent and Trademark Office. The USPTO has given the CONECTA trademark a serial number of 98466226. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, September 26, 2025. This trademark is owned by Montai Health, Inc.. The CONECTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable software featuring machine learning and artificial intelligence for use in the field of healthcare; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis and data mining in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug and chemical analysis in drug discovery and development and for analysis and prediction of compound in-vivo properties; providing online non-downloadable software featuring machine learning and artificial intelligence for diagnostic and therapeutic use and drug response prediction; providing online non-downloadable software using artificial intelligence for use in the pharmaceutical field for discovering and designing compounds and small molecules; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, ...
conecta

General Information


Serial Number98466226
Word MarkCONECTA
Filing DateMonday, March 25, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, September 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Translation of Words in MarkThe English translation of CONECTA in the mark is IT CONNECTS.
Goods and ServicesProviding online non-downloadable software featuring machine learning and artificial intelligence for use in the field of healthcare; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis and data mining in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug and chemical analysis in drug discovery and development and for analysis and prediction of compound in-vivo properties; providing online non-downloadable software featuring machine learning and artificial intelligence for diagnostic and therapeutic use and drug response prediction; providing online non-downloadable software using artificial intelligence for use in the pharmaceutical field for discovering and designing compounds and small molecules; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; scientific research, namely, research and analysis services using artificial intelligence and machine learning in the scientific fields of analytics, pharmaceutical, healthcare, biomedical and genomic research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 30, 2024
Primary Code042
First Use Anywhere DateTuesday, December 20, 2022
First Use In Commerce DateTuesday, December 20, 2022

Trademark Owner History


Party NameMONTAI THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameMONTAI THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameMontai Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, March 25, 2024NEW APPLICATION ENTERED
Wednesday, May 8, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 8, 2024NON-FINAL ACTION E-MAILED
Thursday, October 3, 2024ASSIGNED TO EXAMINER
Monday, December 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 8, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 9, 2025ASSIGNED TO EXAMINER
Wednesday, April 30, 2025USE AMENDMENT FILED
Wednesday, April 30, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, September 24, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, September 26, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 26, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 3, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED